Unaudited Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2025	Dec. 31, 2024
Current assets
Cash and cash equivalents	$ 757,263	$ 449,667
Restricted cash, current	100,000	100,000
Short-term investments	0	330,000
Accounts receivable (net of allowance for credit losses of $22 and $25 as of March 31, 2025 and December 31, 2024, respectively)	76,555	85,178
Notes receivable	11,118	4,233
Inventories, net	53,054	39,875
Prepayments and other current assets	43,878	41,527
Total current assets	1,041,868	1,050,480
Restricted cash, non-current	1,113	1,114
Property and equipment, net	49,654	47,961
Operating lease right-of-use assets	19,081	21,496
Land use rights, net	2,882	2,907
Intangible assets, net	56,198	56,027
Other non-current assets	2,534	5,768
Total assets	1,173,330	1,185,753
Current liabilities
Accounts payable	103,017	100,906
Current operating lease liabilities	6,574	8,048
Short-term debt	173,405	131,711
Other current liabilities	36,811	58,720
Total current liabilities	319,807	299,385
Deferred income	30,126	31,433
Non-current operating lease liabilities	12,319	13,712
Other non-current liabilities	325	325
Total liabilities	362,577	344,855
Commitments and contingencies (Note 17)
Shareholders’ equity
Ordinary shares (par value of $0.000006 per share; 5,000,000,000 shares authorized; 1,089,076,400 and 1,082,614,740 shares issued as of March 31, 2025 and December 31, 2024, respectively; 1,084,164,200 and 1,077,702,540 shares outstanding as of March 31, 2025 and December 31, 2024, respectively)	7	7
Additional paid-in capital	3,283,800	3,264,295
Accumulated deficit	(2,501,521)	(2,453,083)
Accumulated other comprehensive income	49,303	50,515
Treasury Stock (at cost, 4,912,200 shares as of both March 31, 2025 and December 31, 2024)	(20,836)	(20,836)
Total shareholders’ equity	810,753	840,898
Total liabilities and shareholders’ equity	$ 1,173,330	$ 1,185,753
Ordinary shares, shares outstanding (in shares)	1,084,164,200	1,077,702,540
Ordinary shares, shares issued (in shares)	1,089,076,400	1,082,614,740